company mission
The record is thin at the start. In the August 22, 2018 Wayback snapshot, there is no visible mission, belief statement, or theory text at all. That does not prove Cellino lacked a mission then, only that this snapshot does not show one. By January 4, 2019, the company states a clear view: stem cell differentiation should become a digital engineering process, built from optics, biology, and computation. The mission logic is concrete. Cellino ties its approach to three claims: faster production than conventional methods, more functionally mature cells, and deliberately designed mixed cell populations that may improve tissue interconnectivity and engraftment. What changed is not a documented reversal, but the appearance of an explicit theory of the company. What looks stable, at least from the first usable evidence, is a strongly engineering-led view of cell therapy development. Where evidence is thin is obvious: with no readable 2018 mission text, we cannot say whether the 2019 framing was new, or simply newly visible.